Lead sponsor
Dr. Muhammad Abdulghani
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
1
Trials led
0
Active
410
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
1
Trials by status
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DMHbA1c ≥7.5%not applicableUnknown410